INTRODUCTION
The concept that some diseases which apparently have their onset in adult life may, in fact, be programmed by events which occurred in prenatal life is currently the focus of a great deal of investigation [l, 21. Recent analysis has also shown that intrauterine environment has a greater impact on heritability of IQ than previously appreciated [3] . It has been proposed that an adverse intrauterine environment may 'programme' the development of fetal tissues and organs, producing later dysfunction and disease. Such programming reflects the ability of a factor/ factors, acting during a defined developmental stage or 'window', to exert organizational effects that persist throughout life [l, 2, 4-71.
Recent epidemiological data have shown that babies with lower birth weights (small-for-dates, not premature) have a greater chance of developing high blood pressure [4, 5, 81 and non-insulindependent diabetes mellitus [8, 91 as adults, and have increased mortality from ischaemic heart disease [lo, 111. Lower birth weight, in association with a large placenta in some studies, has been demonstrated in several distinct populations to predict higher blood pressure in children [4, 12, 131 and in adult men and women up to late middle age [4-6, Several mechanisms have been proposed to explain this association. Maternal malnutrition, either generalized or restricted to specific dietary components (e.g. protein or iron deficiency), has been suggested to provide a causal link [l, 14, 151 , and indeed in rats, protein restriction during pregnancy leads to elevated blood pressure in the offspring [16, 171. An alternative hypothesis is that fetal exposure to excess maternal glucocorticoid may be a key that explains the relation between birth weight and adult blood pressure [2] . Treatment of pregnant rats with dexamethasone (100 pg day-' kg-I) throughout gestation, which reduced average birth weight by only 14% and did not affect fetal viability or gestational length, caused elevated blood pressure in the adult offspring, many months after the last exposure to glucocorticoid in utero [7] .
Intrauterine growth retardation is associated with elevated fetal cortisol levels [ 181, and exogenously administered glucocorticoid alters tissue growth and maturation in both humans [19] and animals . Furthermore, glucocorticoids increase fetal 81-blood pressure when directly infused in ufero, into immature ovine fetuses [23, 24] .
To date, experimental manipulations of the fetal environment have only been carried out in species with short gestation periods. In order to test the hypothesis that relatively brief prenatal treatment could have long-lasting deleterious consequences in a long-gestation mammal, experiments were designed using sheep. Pregnancy in the sheep lasts approximately 5 months, and the birthweight of the lamb (3.5-4.5 kg) approximates that of the human term baby. Many organs and systems, e.g. the kidney, develop morphologically and endocrinologically in the human and ovine fetus at comparable proportions of total gestation [25, 261 . The prenatal treatments were administered during 1 week at the end of the first and second months of gestation and consisted of transport of the pregnant ewe from the farm to the Institute, cannulation of the ewes, and infusion of a synthetic glucocorticoid (dexamethasone) for 48 h. The outcome variables included basal blood pressures and hormones, and the cardiovascular responsiveness to graded doses of angiotensin I1 and noradrenaline, or a 5 day adrenocorticotropic hormone (ACTH) treatment, at 4, 10 and 19 months of age. The mean ages at which the prenatal treatments were given were 22 k0.4 to 29 k0.4 days [pretreatment group 1 (PTGI)] and 59 f 2 to 66 f 2 days [pretreatment group 2 (PTG2)] respectively.
The dose of dexamethasone used and the times of administration during pregnancy were based on previous studies [27-301.
METHODS

Animals
Five days before dexamethasone treatment began, pregnant Merino ewes of known mating date were transported from the farm to the Howard Florey Institute (distance of 20 km). While at the Institute ewes were maintained in individual metabolism cages and provided with food (lucerne and chaff) and water ad libitum. Two days after completion of dexamethasone infusion, pregnant sheep were returned to the farm where they were allowed to lamb. While on the farm the animals were provided with fresh grass and water ad libitum.
Dexamethasone (Decadron; Merck, Sharp and Dohme, NSW, Australia), 0.28 mg day-' kg-', was infused in normal saline at 0.19 m l k for 48 h via an indwelling jugular vein cannula (inner diameter, 0.58 mm; outer diameter, 0.97 mm) inserted under local anaesthesia at least 24 h before the infusion. Maternal blood samples were taken from the jugular vein before and after dexamethasone treatment for the measurement of maternal plasma ACTH levels.
Ewes in PTGl (n = 8) gave birth to six female and three male lambs, including one set of twins. Ewes in PTG2 (n = 12) gave birth to seven female and four male lambs. In this group of ewes, one pregnancy ended with abortion 24 h after the dexamethasone infusion ceased. Only female lambs (n = 13) were included in further studies, for practical purposes, there being fewer male offspring.
For controls we used seven female lambs (including one set of twins) from sheep which had not been exposed to the stress of transportation to and from the Institute and/or cannulation. Therefore these animals were exposed to a minimum stress during development.
Lambs (dexamethasone-treated and control) were weaned from their mothers when 40days old and brought to the Institute. They were put on the same diet-mixture of lucerne and chaff regularly supplemented with vitamins and salt to ensure normal growth. Surgery (oophorectomy and carotid artery loops) was performed on all lambs at 50 days of age. Oophorectomy was performed to eliminate potential effects of oestrus cycles.
Experimental protocol
Basal blood pressure and blood pressure responsiveness to noradrenaline (NA), angiotensin I1 (ANG 11) and ACTH, were studied in lambs at 100, 300 and 560 days of age. Dose-response curves were constructed for NA (1.4, 2.8, 5.6, 14.0, 28.0 and 56.0 pg h-' kg-', intravenously in saline) and ANG I1 (0.11, 0.22, 0.55, 1.10 and 2.20 pg h-' kg-', intravenously in saline); each dose was infused for 10 min. Mean arterial pressure and heart rate were measured via a Tygon cannula (inner diameter, 1.0 mm; outer diameter, 1.5 mm) inserted into a carotid artery and connected to a pressure transducer (TD XIII, Cobe) (placed at the level of the heart) and recorded continuously during infusions on a Gould 3000 series chart recorder (Gould Inc., Cleveland, OH, USA.).
ACTH (1-24, CIBA; 5 pg day-' kg-') was infused intravenously in saline at 1.2 ml/h for 5 days. Lambs were infused with normal saline (1.2 m l k ) for 3 preinfusion and 3 postinfusion days. Arterial pressure was measured continuously via a Tygon cannula (inner diameter, 1.0 mm; outer diameter, 1.5 mm) inserted 10 cm proximally into a carotid artery loop. The cannula was connected to a pressure transducer (TD XIII, Cobe), tied to the wool on the sheep's back, and patency was maintained by infusing heparinized saline (25 units/ml) at 3 m l k from a flush device (TDF-3WC; Biosensors International, Singapore). The signal from the pressure transducer was amplified and calibrated daily against a mercury manometer. The pressure was corrected to compensate for the height of the transducer above the level of the heart. Heart level was taken as 64% of the distance from the back to the sternum, which is the level of the junction of the left atrium with the left atrial appendage [31] . Analog signals were collected with a personal computer 486 data acquisition system using custom software. After analog to digi-tal conversion (DT 2811 Board, Data Translation), the data were collected at 100Hz for 1 0 s every 10 min.
For all lambs, blood samples were taken at approximately 10.00 hours from the carotid artery on days 3, 4, 6, 8 and 11 for measurement of plasma Na+, K+, osmolality, glucose, total protein, plasma renin and cortisol concentrations.
Sample analysis
Plasma solutes (Na+, K+, glucose, total protein) were measured on a Synchron CX5 Clinical System (Beckman, Fullerton, CA, U.S.A.). Osmolality was measured by freezing point depression using an Advanced Instruments Osmometer (Advanced Instruments, Needham Heights, MA, U.S.A.). Measurement of plasma renin concentration was determined using a modification of the antibody capture technique, by measuring the generation of angiotensin I (sensitivity, 0.2 pmol h-' ml-l; interassay variation, 9%) [32] . Plasma cortisol was measured by radioimmunoassay of extracted plasma (sensitivity, 0.2 nmol/l; interassay variation, 8.7%) [33] . Measurement of plasma ACTH was performed on unextracted plasma (sensitivity, 2 pg/ml; interassay variation, 11 %) using an ACTH immunoradiometric kit (DYNO test; Henning GmbH, Berlin, Germany).
Statistics
One-way analysis of variance with Bonferroni (modified t-test) was used to compare basal mean arterial pressures. Differences between treatments in blood pressure responsiveness to NA, ANG I1 and ACTH were tested by repeated measures analysis of variance. Statistical analysis was performed using the SPSS statistical program.
RESULTS
Dexamethasone treatment at 0.28 mg day-' kg-' for 2 days, reduced maternal plasma ACTH concentrations from 4 7 f 8 to <5 pg/ml (P<O.OOl) in 13 ewes. Term was 150 f 2 (PTG1) and 148f2 days (PTG2), respectively, compared with control where term was 150 4 2 days.
There were no significant differences in the birth weights of lambs in the two treatment groups (4.8 f 0.3 kg, PTG1; 4.2 f 0.3 kg, PTG2) compared with the control group of lambs (birth weight 4.6f0.2 kg). In addition, the body weights of all lambs were similar at 100, 300 and 560 days of age (body weights were measured before each set of experiments).
Blood pressure was examined first when lambs were 11042 (control; n = 7), 124f5 (PTG1; n = 6) and 104f4 (PTG2; n = 7) days old. Basal mean arterial pressure was significantly higher in the offspring of sheep of the earliest treatment group (PTG1) compared with the control group (80 f 1 mmHg versus 74 f 2 mmHg; P < 0.05) (Fig.  1) . The mean arterial pressure response to NA, ANG I1 and ACTH (Figs 2a, 3a and 4a ) was similar in all lambs studied.
The second set of experiments testing basal blood pressure and blood pressure responsiveness to NA, ANG I1 and ACTH was performed at 323 & 7 (control; n = 7), 309 f 8 (PTG1; n = 6) and 285 f 7 days (PTG2; n = 7). The significant difference in basal mean arterial pressure (found with first testing) between the control group (76 f 1 mmHg) and PTGl (83 f 1 mmHg; P<0.05) was sustained at this age (Fig. 1) . Neither treatment group had altered pressure sensitivity to NA, ANG I1 and ACTH ( Figs  2b, 3b and 4b) .
The last series of experiments studying the prenatal exposure to glucocorticoids on adult basal and stimulated blood pressure were carried out at 568f17 (control; n = 7), 558f21 (PTG1; n = 6) and 561 k 9 (PTG2; n = 7) days of age. Basal mean arterial pressure in PTGl was again significantly elevated compared with control (89 f 1 mmHg versus 81 f 1 mmHg; P<0.05) and also when compared with PTG2 (81 f 3 mmHg; P<O.O5) (Fig. 1) . Blood pressure responsiveness to NA, ANG I1 and ACTH was similar in control and both treatment groups of lambs (Figs 2c,3c and 4c ).
Lambs in PTG2 had similar basal mean arterial pressures when compared with control at all age groups studied (Fig. 1) . Basal mean arterial pressure significantly changed with age in the control group (P<O.O5) and PTGl (P<O.OOl) but not in PTG2. There were no differences in basal plasma Na+, K+, glucose, total protein, cortisol and renin concentrations in the offspring of the treatment groups when compared with the control group (Table 1) . Also, ACTH treatment (5 pg day-' kg-') for 5 days decreased plasma K+ and increased plasma glucose concentrations consistently in all lambs studied, by a similar magnitude in all groups at all ages (results not shown). The effects of endogenous ACTH on plasma cortisol concentrations at days 1, 3 and 5 of ACTH infusion, and the 3 days after cessation of ACTH infusion, are shown in Table 2 . There was no significant difference between the three groups. a) 140 , NORADRENALINE -1 OOd. 
DISCUSSION
The major finding from this study was that prenatal treatment at the end of the first, but not the second, month of gestation resulted in lambs which had significantly higher blood pressures from 4 to 19 months of age. Even though the 6-8 mmHg rise in basal mean arterial pressure observed in our study was small in absolute terms, it is similar to that found in other studies in rats [7, 34, 351 ,guinea pigs [36] and humans [4, 51. Although it is possible that the elevation in blood pressure resulted from fetal exposure to a combination of excess of endogenous and exogenous glucocorticoid, it is most likely that the high dose of dexamethasone, administered over only 48 h, was the critical signal. Dexamethasone can cross the ovine placenta and alter fetal function and placental morphology [28, 371; therefore prenatal dexamethasone could have had its long-term effect by permanently altering some aspect of fetal physiology directly. It has been suggested, largely from experiments in rats, that prenatal stress can alter the normal setting of the hypothalamic-pituitary-adrenal axis, so that there are higher steroid levels circulating after birth [38-401. At the time at which 'programming' occurs the neuronal tube is closed, the hypophyses (both glandular and nervous parts) are visible, and some cells, exhibiting immunoreactivity to serotonin [41] or tyrosine hydroxylase [42] , can be demonstrated in the medioventral part of the mesencephalic flexure.
Neither basal nor ACTH-stimulated plasma cortisol concentrations were apparently affected in lambs by any prenatal treatment. Thus there is no ready explanation for any 'programming' effect on the hypothalamic-pituitary-adrenal axis. It would be most interesting, when these sheep are ultimately killed, to examine the status of expression of hippocampal mineralocorticoid and glucocorticoid receptors, which are altered by prenatal dexamethasone treatment in rats [39] .
Another mechanism which might impinge on basal blood pressure concerns the development of the kidney and the renin-angiotensin-aldosterone system. It has been observed that human subjects inheriting glucocorticoid-suppressible hyperaldosteronism from their mothers showed significantly higher plasma aldosterone concentrations and mean arterial pressures than those inheriting the disease from their fathers [43] , suggesting that chronic exposure in utero to elevated plasma aldosterone resulted in permanent programming of blood pressure. Also, in cases of intrauterine growth retardation, the kidney has been shown to be particularly susceptible to defects in organogenesis [44, 451, and the smaller the kidney, the higher the cord blood renin and ANG I1 levels [45, 461. However, the lambs in our study were not growth retarded, and plasma renin concentrations were normal as were the pressor responses to exogenous ANG 11. Nevertheless, it may be worthwhile investigating the renin-angiotensin system (angiotensinogen, plasma concentrations [47] . Therefore, the kidney renin-angiotensin system could hardly be affected by dexamethasone. Preliminary studies have shown that the pressor responsiveness to ANG I1 was not affected by prenatal treatment with dexamethasone in hypertensive offspring of Wistar rats, nor was there evidence of dexamethasone-induced changes in vascular structure of smooth muscle cell proliferation [48] . The third major mechanism by which prenatal dexamethasone may have 'programmed' subsequent hypertension is by causing an alteration in sympathetic innervation, drive or receptors. There is evidence, both from studies in rats and sheep, that prenatal exposure to excess glucocorticoids can enhance cardiac and renal adenylate cyclase responses to agonists, and interfere with the establishment of cardiac noradrenergic innervation and sympathetic activity [20] [21] [22] 491 . There was no enhanced pressor responsiveness to exogenous noradrenaline in the hypertensive lambs in the current study, but the level of activation of the sympathetic nervous system was not studied.
A fourth mechanism leading to hypertension could be remodelling of structures in the cardiovascular system, possibly leading to increased vascular responsiveness to pressor agents. The finding that the responsiveness to ANG 11, NA and ACTH was normal in the offspring of FTGl indicated that increased vascular responsiveness to these agents was not the cause of the elevated blood pressure.
It is not known whether dexamethasone produced its effect by action on classical glucocorticoid receptors, as dexamethasone can exert biological effects independently of binding to classical glucocorticoid receptors [50, 511.
The prenatal treatment which affected adult blood pressure may not have exerted its effects directly on the fetus, but may have altered some aspect of placental development. It has been suggested that prenatal undernutrition (from -60 to +30 days around conception) can alter the insulin/ glucose relationships months later [52] . The placenta is quite small, and undergoing significant morphological development, at the time when the treatment appears to result in adult hypertension.
In conclusion, it has been shown that a prenatal treatment which included exposure of the fetus to excess glucocorticoid at one particular time, early in gestation, in a long-gestation species, the sheep, can result in prolonged elevated levels of blood pressure for at least 19months after birth. This effect could not be linked to any alteration in the postnatal state of the hypothalamic-pituitary-adrenal axis, the renin-angiotensin system, or altered pressor responses to noradrenaline, ANG I1 or ACTH.
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